D.J. St. Germain’s AstraZeneca AZN Stock Holding History

D.J. St. Germain’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.8K	Buy	247 +80	+48%	+$15K	﹤0.01%	480
2026 Q1	$32.9K	Sell	167 -1	-0.6%	-$193	﹤0.01%	510
2025 Q4	$30.9K	Hold	168	–	–	﹤0.01%	529
2025 Q3	$25.8K	Buy	168 +15	+10%	+$2.27K	﹤0.01%	551
2025 Q2	$21.3K	Hold	153	–	–	﹤0.01%	571
2025 Q1	$22.4K	Buy	153 +61	+66%	+$8.83K	﹤0.01%	494
2024 Q4	$12K	Hold	92	–	–	﹤0.01%	566
2024 Q3	$14.3K	Buy	92 +22	+31%	+$3.55K	﹤0.01%	500
2024 Q2	$10.9K	Buy	70 +50	+250%	+$7.52K	﹤0.01%	523
2024 Q1	$2.71K	Sell	20 -60	-75%	-$7.95K	﹤0.01%	661
2023 Q4	$10.8K	Sell	80 -33	-29%	-$4.29K	﹤0.01%	553
2023 Q3	$15.2K	Hold	113	–	–	﹤0.01%	491
2023 Q2	$16.1K	Buy	+113	New	+$16.6K	﹤0.01%	496
2022 Q4	$12.9K	Buy	+96	New	+$12K	﹤0.01%	269

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.J. St. Germain's AZN Position: Q2 2026 in Review

D.J. St. Germain increased its AstraZeneca (AZN) stake by 48% in Q2 2026, buying an estimated $15K and bringing the position to 247 shares worth $46.8K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

D.J. St. Germain first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

D.J. St. Germain held 247 shares of AstraZeneca worth $46.8K as of Q2 2026.
D.J. St. Germain bought 80 AstraZeneca shares in Q2 2026, an estimated $15K.
AstraZeneca made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #480 holding.
D.J. St. Germain first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.